Supplementation of methylseleninic acid inhibited HDAC activity in B-cell lymphoma cell lines [111] and in esophageal squamous cell carcinoma cell lines [112]. The gene discussed is HDAC9; the disease is B-cell non-Hodgkin lymphoma.